Pfizer bids $100 million to acquire Australian COVID-19 testing startup

bids

Global pharmaceutical giant Pfizer has made a $100 million bid to acquire eight-year-old Australian diagnostic technology company ResApp, as HealthTech continues to attract attention amid the ongoing pandemic. The Brisbane start-up told investors on Monday it entered a scheme of arrangement with Pfizer, according to reporting by the Nine newspapers. The acquisition could see the American pharma […]

This website uses cookies to ensure you get the best experience on our website.